2023
DOI: 10.1002/exp.20220086
|View full text |Cite
|
Sign up to set email alerts
|

Mesoporous silica/organosilica nanoparticles for cancer immunotherapy

Abstract: Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano-platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Es… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(11 citation statements)
references
References 129 publications
0
11
0
Order By: Relevance
“…The employment of porous silicon and MSNs/MONs as vehicles and immunotherapy nanoplatforms has been comprehensively summarized in several previous reviews. 188,596,597 Here, we will emphasize the intrinsic immunogenicity of silicon-composed biomaterials.…”
Section: Biological Effects Of Silicon-containing Biomaterialsmentioning
confidence: 99%
“…The employment of porous silicon and MSNs/MONs as vehicles and immunotherapy nanoplatforms has been comprehensively summarized in several previous reviews. 188,596,597 Here, we will emphasize the intrinsic immunogenicity of silicon-composed biomaterials.…”
Section: Biological Effects Of Silicon-containing Biomaterialsmentioning
confidence: 99%
“…They are widely used in drug delivery and biomedical fields due to their simple synthesis process, large surface area, and controllable structural parameters. [58][59][60] Tan et al fabricated HMON-LOD by attaching LOX to the shell surface of hollow mesoporous organosilicon nanoparticles (HMONs). HMON-LOD is safer than free LOX, which resulted in the death of mice when administered intravenously.…”
Section: Lox-based Inorganic Nanocarriers For Tumour Therapymentioning
confidence: 99%
“…Among various inorganic nanoparticles, silica nanoparticles have merits such as high surface modifiability, good biocompatibility, enzyme stability, and low cost. [66,67] In recent years, oral applications based on silica nanoparticles have been gradually increasing.…”
Section: Silica Nanoparticle-based Oral Nanomedicinementioning
confidence: 99%